PharmacoEconomics – Call For Papers

FeaturedPharmacoEconomics – Call For Papers

Productivity Costs and non-Health Care Consumption Costs

PharmacoEconomics invites the submission of papers (original research, reviews, opinion and tutorial pieces) on estimating productivity costs and non-medical consumption costs, and the implications for health-related decision making, for a themed issue of the journal to be published at the end of 2022 and guest edited by Professors Werner Brouwer and Pieter van Baal.

We encourage papers from the perspectives from a variety of stakeholders including payers, health technology assessment bodies, health economists, employers, pharmaceutical industry, policy makers, patients and caregivers, and advocacy groups. Special patient population perspectives and papers developing or employing novel methods are particularly encouraged. Papers can be either methodological or applied.

Topics of interest include:

  • Applied papers on Disease Burden
  • Productivity Costs (Presenteeism and absenteeism)
  • Lost productivity of caregivers
  • Relationship between Productivity Loss and HRQOL
  • Applied papers on Consumption Costs
  • Estimates of non-medical costs (e.g. housing and food) in various patient populations
  • Impact of consumption on utility estimates
  • Impact of Productivity and Consumption Costs
  • Impact on cost effectiveness
  • Impact on decision making
  • Impact on valuation of health
  • Methodological Challenges and Unresolved Issues
  • Instrument selection
  • Development and validation of new instruments
  • Survey methods (self report, observation, online, etc)
  • Valuation methods
  • Compensation mechanisms and Multiplier-effects
  • Estimating workplace burden
  • Estimating the Friction Cost period
  • Do QALY’s capture benefits from nonmedical consumption and production?
  • Country specific considerations including LMIC
  • Impact of Covid
  • Transferability of estimates
  • Addressing Uncertainty

Please submit an abstract describing your proposed paper by March31st, 2022 to Full papers will be invited by April 30th 2022 and manuscripts due by September 15th  2022

PharmacoEconomics is published by Springer Nature. It is indexed in all major databases and has an Impact Factor of 4.98. Further journal metrics can be found here

Call for papers: Special Issue – Family Spillover Effects of Illness

Call for papers: Special Issue – Family Spillover Effects of Illness

PharmacoEconomics invites the submission of manuscripts with a focus on family spillover effects of illness for a special issue of the journal to be published in 2018.

PEC low res 40273_035_004
Cover image of Pharmaco-Economics

The issue will focus on methods and applications for measuring spillover effects as well as conceptual papers discussing methodological and practical issues.

In a paper previously published in PharmacoEconomics, Guest Editors Eve Wittenberg and Lisa Prosser state:

Caring for an ill or disabled family member imposes a well-documented burden on the caregiver. The benefits of a health intervention may be underestimated if “spillover” effects on family members are not captured, resulting in inaccurate conclusions of economic evaluations.

For the context of this special issue, family spillover is defined as the effect on an individuals’ quality of life due to having a family member with a chronic illness. We consider spillover to include family caregivers as well as non-caregivers. Extensions to larger social networks may also be included with justification (e.g., classmates for children’s illnesses).

Topics of interest include:

  • Applications: Measurement of spillover for specific conditions or populations of interest, inclusion of spillover in cost-effectiveness analyses.
  • Methods: Conceptual frameworks, measurement tools or approaches, methodological or practical issues in measurement; challenges to application in CEA.

Please submit an abstract describing your proposed paper by July 31, 2017 to the Editor, Chris Carswell . Full papers will be invited by August 31, 2017 and manuscripts due in early 2018.